glp 1 masld Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists GLP-1 therapies target MASLD/MASH pathophysiology
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


























